Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Managing Challenging Behaviors-ADHD [NA]
A completed clinical trial at Dartmouth-Hitchcock Medical Center evaluated a psychosocial intervention for challenging behaviors in attentio…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Neurofeedback Training's Efficiency for Attentionnal Performances [NA]
Clinical trial update describes a study evaluating the effectiveness of neurofeedback training for improving attention performance in indivi…
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms
A completed clinical trial investigated whether fatty acids influence symptoms of attention deficit hyperactivity disorder in children, incl…
-
FDA approval · 2024-06-14FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a Supplemental Application from Sandoz Inc for a generic combination product containing dextroamphetamine saccharate, amphetami…
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
This clinical trial is evaluating whether sulphonylureas improve neurodevelopmental outcomes in individuals with KCNJ11-related iDEND syndro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-06-12FDA Approved: GUANFACINE — Original Application (Fosun Pharma USA, Inc)
FDA approved the original application for guanfacine from Fosun Pharma USA, Inc, providing a generic version of guanfacine.
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Acute Effects of Exercise in College Students With ADHD [NA]
Recruitment is ongoing for a University of Wyoming study on the acute effects of exercise on attention and working memory in college student…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Acute Effects of Stimulant Medication in College Students With ADHD [Phase 2]
Clinical trial update describing a Phase 2 study on the acute effects of stimulant medication in college students with ADHD; the trial is cu…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Randomized Controlled Trial of a Behavioral Training App [NA]
A randomized controlled trial is evaluating a behavioral training app for children with disruptive behavior and related symptoms. The study …
-
FDA approval · 2024-06-06FDA Approved: METHAMPHETAMINE HYDROCHLORIDE — Supplemental Application (Mayne Pharma Commercial LLC)
FDA approved a supplemental application for methamphetamine hydrochloride from Mayne Pharma Commercial LLC.
-
FDA approval · 2024-06-04FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Solco Healthcare US,LLC)
FDA approved a supplemental application for lisdexamfetamine dimesylate capsules submitted by Solco Healthcare US, LLC. The approval covers …
-
FDA approval · 2024-06-03FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC.)
The FDA approved a supplemental application for methylphenidate hydrochloride from KVK-Tech, Inc., authorizing their generic product under a…
-
FDA approval · 2024-05-30FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic formulation containing four amphetamine salt components (dextroamphetamine saccharate,…
-
FDA approval · 2024-05-24FDA Approved: ONYDA XR — Original Application (NextWave Pharmaceuticals, Inc)
FDA approved ONYDA XR (clonidine hydrochloride) from NextWave Pharmaceuticals as a new extended-release treatment for attention-deficit/hype…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4) [Phase 3]
Phase 3 CHIME 4 trial evaluating impulsive aggression treatment in ADHD subjects terminated; results have been posted.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Assessment of Neurocognitive Rehabilitations of Inhibition of Disorders in ADHD in Children (ERNTITDAH) [NA]
This clinical trial update confirms the completion of the pediatric ADHD neurocognitive rehabilitation trial ERNTITDAH (NCT02405299). The st…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: FOCUS ADHD Mobile Health App for Adult ADHD Patients [NA]
Completed clinical trial update for the FOCUS ADHD mobile health app in adult ADHD patients; trial phase not reported.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD [Phase 2]
A Phase 2 placebo-controlled study evaluating homeopathic treatment for attention-deficit/hyperactivity disorder in children and youth has c…
-
FDA approval · 2024-05-13FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Cranbury Pharmaceuticals, LLC)
FDA granted a supplemental approval for methylphenidate hydrochloride from Cranbury Pharmaceuticals, LLC, updating the approved generic prod…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Impact of A Multidimensional Health Education Program on Attention Deficit Hyperactivity Disorder (ADHD) [NA]
An update on a multidimensional health education program for Attention-deficit/hyperactivity disorder is provided. The trial is currently ac…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Cognitive Behavioral Therapy for University Students Diagnosed With Attention-deficit Hyperactivity Disorder (ADHD) [NA]
This entry reports a clinical trial update studying cognitive behavioral therapy for university students diagnosed with ADHD, sponsored by t…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Brain Activity Associated With Inhibition of Action in Attention-deficit [NA]
This clinical trial update indicates a recruiting study at University Hospital, Toulouse investigating brain activity related to inhibition …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Managing Young People With ADHD in Primary Care Study
A University of Exeter–led clinical trial on managing ADHD in young people in primary care has reached completion.
-
CLINICAL_TRIALS other · 2024-05-08Clinical Trial Update: Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD [Phase 1, Phase 2]
A University of British Columbia trial is evaluating the effects of low-dose versus normal-dose psychostimulants on executive function in in…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Oxytocin and Cognitive Control in Adult ADHD [EARLY_Phase 1]
A completed EARLY_PHASE1 trial from Massachusetts General Hospital evaluated oxytocin for cognitive control in adults with Attention Deficit…